Kirsch Arthur S
SEC-identified person · CIK 1290976 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Atea Pharmaceuticals, Inc. AVIR | Director | filed 2025 - 2026 |
| Liquidia Corp LQDA | Director | filed 2021 - 2026 |
| Evommune, Inc. EVMN | Director | filed 2025 - 2026 |
| Kadmon Holdings, LLC kdmn | Director | filed 2019 - 2021 |
| Liquidia Technologies Inc LQDA | Director | filed 2018 - 2020 |
| Aralez Pharmaceuticals Inc. ARLZ | Director | filed 2016 - 2017 |
| Pozen INC /NC POZN | Director | filed 2006 - 2016 |
| Immunomedics INC IMMU | Director | filed 2015 - 2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.